Evidence map›Paper›PMID 27170758›Full record

ArticleJournal of virology2016

Identification of a Functionally Relevant Adeno-Associated Virus Rep68 Oligomeric Interface.

Martino Bardelli, Francisco Zárate-Pérez, Leticia Agúndez, R Michael Linden, Carlos R Escalante, Els Henckaerts

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Martino BardelliDepartment of Infectious Diseases, King's College London, London, United Kingdom.
Francisco Zárate-PérezDepartment of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Leticia AgúndezDepartment of Infectious Diseases, King's College London, London, United Kingdom.
R Michael LindenDepartment of Infectious Diseases, King's College London, London, United Kingdom.
Carlos R EscalanteDepartment of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA carlos.escalante@vcuhealth.org els.henckaerts@kcl.ac.uk.
Els HenckaertsDepartment of Infectious Diseases, King's College London, London, United Kingdom carlos.escalante@vcuhealth.org els.henckaerts@kcl.ac.uk.
King's College London · GBVirginia Commonwealth University · US

Funding

AAV Rep-DNA Complexes Underlaying Site-specific IntegrationR01GM092854 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI ESCALANTE, CARLOS R · 2010 to 2013
$1.1M
Medical Research Council 1001764NIGMS NIH HHS R01 GM092854
6 · The paper itself

Abstract

unlabelledThe life cycle of the human parvovirus adeno-associated virus (AAV) is orchestrated by four Rep proteins. The large Rep proteins, Rep78 and Rep68, are remarkably multifunctional and display a range of biochemical activities, including DNA binding, nicking, and unwinding. Functionally, Rep78 and Rep68 are involved in transcriptional regulation, DNA replication, and genomic integration. Structurally, the Rep proteins share an AAA(+) domain characteristic of superfamily 3 helicases, with the large Rep proteins additionally containing an N-terminal origin-binding domain (OBD) that specifically binds and nicks DNA. The combination of these domains, coupled with dynamic oligomerization properties, is the basis for the remarkable multifunctionality displayed by Rep68 and Rep78 during the AAV life cycle. In this report, we describe an oligomeric interface formed by Rep68 and demonstrate how disruption of this interface has drastic effects on both the oligomerization and functionality of the Rep proteins. Our results support a role for the four-helix bundle in the helicase domain of Rep68 as a bona fide oligomerization domain (OD). We have identified key residues in the OD that are critical for the stabilization of the Rep68-Rep68 interface; mutation of these key residues disrupts the enzymatic activities of Rep68, including DNA binding and nicking, and compromises viral DNA replication and transcriptional regulation of the viral promoters. Taken together, our data contribute to our understanding of the dynamic and substrate-responsive Rep78/68 oligomerization that is instrumental in the regulation of the DNA transitions that take place during the AAV life cycle. IMPORTANCE: The limited genome size of small viruses has driven the evolution of highly multifunctional proteins that integrate different domains and enzymatic activities within a single polypeptide. The Rep68 protein from adeno-associated virus (AAV) combines a DNA binding and endonuclease domain with a helicase-ATPase domain, which together support DNA replication, transcriptional regulation, and site-specific integration. The coordination of the enzymatic activities of Rep68 remains poorly understood; however, Rep68 oligomerization and Rep68-DNA interactions have been suggested to play a crucial role. We investigated the determinants of Rep68 oligomerization and identified a hydrophobic interface necessary for Rep68 activity during the AAV life cycle. Our results provide new insights into the molecular mechanisms underlying the regulation of the versatile Rep proteins. Efficient production of AAV-based gene therapy vectors requires optimal Rep expression levels, and studies such as the one presented here could contribute to further optimization of AAV production schemes.

Indexed as

DNA ReplicationDNA-Binding ProteinsDNA, ViralHumansMutagenesis, Site-DirectedMutationProtein BindingProtein ConformationProtein MultimerizationViral ProteinsDNA-Binding ProteinsDNA, Viralrep proteins, Adeno-associated virus 2Viral Proteins

Identifiers

PMID27170758
PMCPMC4944284
OpenAlexW2470491938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.